Glycominds, a commercial stage diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease biomarkers with a distinctive focus on the Inflammatory Bowel Disease (IBD).
Looking for a particular Glycominds, LLC employee's phone or email?
The Glycominds, LLC annual revenue was $5 million in 2026.
Glycominds, LLC is based in Simi Valley, California.
The NAICS codes for Glycominds, LLC are [325, 3254, 32541, 325413, 32].
The SIC codes for Glycominds, LLC are [28, 283].